{"id":"https://openalex.org/W4382811366","doi":"https://doi.org/10.1016/j.annonc.2023.04.443","title":"P-387 Rechallenge with anti-EGFR antibodies in metastatic colorectal cancer: A single center analysis","display_name":"P-387 Rechallenge with anti-EGFR antibodies in metastatic colorectal cancer: A single center analysis","publication_year":2023,"publication_date":"2023-06-01","ids":{"openalex":"https://openalex.org/W4382811366","doi":"https://doi.org/10.1016/j.annonc.2023.04.443"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2023.04.443","doi":"https://doi.org/10.1016/j.annonc.2023.04.443","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.04.443","pdf_url":"http://www.annalsofoncology.org/article/S0923753423005859/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4382811366"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S0923753423005859/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063556091","display_name":"Ana Duarte Mendes","orcid":"https://orcid.org/0000-0003-0320-1740","observed_orcids":["https://orcid.org/0000-0003-0320-1740"]},"institutions":[{"id":"https://openalex.org/I4210099144","display_name":"Hospital Prof. Dr. Fernando Fonseca","ror":"https://ror.org/010bsbc18","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210099144"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"A. Duarte Mendes","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210099144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015170004","display_name":"Rodrigo Santos Vicente","orcid":"https://orcid.org/0000-0001-6780-4271","observed_orcids":["https://orcid.org/0000-0001-6780-4271"]},"institutions":[{"id":"https://openalex.org/I4210099144","display_name":"Hospital Prof. Dr. Fernando Fonseca","ror":"https://ror.org/010bsbc18","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210099144"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"R. Vicente","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210099144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023087838","display_name":"Telma Cale\u00e7a","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099144","display_name":"Hospital Prof. Dr. Fernando Fonseca","ror":"https://ror.org/010bsbc18","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210099144"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"T. Cale\u00e7a","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210099144"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005416414","display_name":"M. Silva","orcid":"https://orcid.org/0009-0009-7259-143X","observed_orcids":["https://orcid.org/0009-0009-7259-143X"]},"institutions":[{"id":"https://openalex.org/I4210099144","display_name":"Hospital Prof. Dr. Fernando Fonseca","ror":"https://ror.org/010bsbc18","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I4210099144"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"M. Silva","raw_affiliation_strings":["Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Professor Doutor Fernando Fonseca, Entidade P\u00fablica Empresarial, Lisbon, Portugal","institution_ids":["https://openalex.org/I4210099144"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210099144"],"apc_list":{"value":4060,"currency":"USD","value_usd":4060},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":null,"first_page":"S149","last_page":"S149"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9300000071525574},{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.8190000057220459},{"id":"https://openalex.org/keywords/rechallenge","display_name":"drug rechallenge","score":0.6480000019073486},{"id":"https://openalex.org/keywords/ras-wild-type","display_name":"RAS wild-type","score":0.7049999833106995},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.9319999814033508},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8429999947547913},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9010000228881836},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-lines","display_name":"treatment lines","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9732033610343933},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.663611888885498},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.620254635810852},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5953416228294373},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.48502296209335327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44226503372192383},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1537877917289734}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2023.04.443","doi":"https://doi.org/10.1016/j.annonc.2023.04.443","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.04.443","pdf_url":"http://www.annalsofoncology.org/article/S0923753423005859/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2023.04.443","doi":"https://doi.org/10.1016/j.annonc.2023.04.443","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.04.443","pdf_url":"http://www.annalsofoncology.org/article/S0923753423005859/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320327845","display_name":"Ono Pharmaceutical","ror":"https://ror.org/022jefx64"},{"id":"https://openalex.org/F4320330066","display_name":"Sirtex Medical","ror":"https://ror.org/05gt90n14"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382811366.pdf","grobid_xml":"https://content.openalex.org/works/W4382811366.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3015725420","https://openalex.org/W4391035959","https://openalex.org/W4394602714","https://openalex.org/W3092816113","https://openalex.org/W3153189337","https://openalex.org/W3041561982","https://openalex.org/W4319023497","https://openalex.org/W2954095910","https://openalex.org/W4401052054","https://openalex.org/W7127594921"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2023-07-02T00:00:00"}
